Coinbase
COIN
MARA Holdings
MARA
Ecopetrol
EC
Meta Platforms
META
MicroStrategy
MSTR
US Stock MarketDetailed Quotes
EGRX Eagle Pharmaceuticals
- 0.800
- +0.050+6.67%
15min DelayTrading Jan 23 11:22 ET
10.37MMarket Cap0.91P/E (TTM)
1.050High0.430Low18.96KVolume0.430Open0.750Pre Close12.97KTurnover0.23%Turnover Ratio0.29P/E (Static)12.96MShares6.81052wk High0.04P/B6.69MFloat Cap0.00352wk Low--Dividend TTM8.36MShs Float104.170Historical High--Div YieldTTM82.67%Amplitude0.003Historical Low0.684Avg Price1Lot Size
Eagle Pharmaceuticals Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | (FY)Dec 31, 2021 | (Q4)Dec 31, 2021 | (Q3)Sep 30, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -100.29%-126K | -101.75%-33.51M | 79.67%50.7M | 364.76%37.56M | -1,340.58%-13.24M | 400.31%42.99M | -258.53%-16.61M | -42.99%28.22M | -59.10%8.08M | -81.04%1.07M |
| Net income from continuing operations | 154.65%5.16M | -86.95%5.75M | 513.14%35.64M | 231.78%8.17M | -26.84%-7.13M | -361.63%-9.45M | 10,565.08%44.06M | -171.96%-8.63M | -176.90%-6.2M | -179.64%-5.62M |
| Operating gains losses | -106.54%-210K | -83.04%326K | 79.85%9.86M | -264.32%-6.06M | 352.68%10.79M | -35.97%3.21M | 134.32%1.92M | 3.47%5.48M | 174.52%3.69M | -60.59%2.38M |
| Depreciation and amortization | 241.49%5.58M | 512.33%5.56M | 219.79%12.02M | 427.65%5.63M | 326.58%3.85M | 82.77%1.63M | 1.34%908K | 6.27%3.76M | 20.84%1.07M | 4.76%903K |
| Deferred tax | 11.38%-1.78M | 10.24%-2.18M | -130.07%-8.32M | -230.05%-3.58M | 91.84%-298K | -1,027.65%-2.01M | -369.62%-2.43M | -139.44%-3.62M | -778.13%-1.09M | -383.71%-3.65M |
| Other non cash items | 190.27%1.16M | 11.78%446K | -31.91%1.45M | -83.94%178K | 103.02%471K | 26.10%401K | -15.11%399K | -53.83%2.13M | -66.71%1.11M | -63.00%232K |
| Change In working capital | -131.83%-14.23M | 26.93%-48.05M | -272.00%-16.4M | 504.24%29.11M | -993.35%-24.46M | 878.80%44.71M | -951.50%-65.76M | 1,068.75%9.54M | -19.18%4.82M | 121.16%2.74M |
| -Change in receivables | -100.41%-186K | 52.61%-42.52M | -423.56%-30.83M | 485.12%24.49M | -250.37%-11.01M | 682.70%45.4M | -1,644.06%-89.71M | 406.10%9.53M | 286.88%4.19M | 235.18%7.32M |
| -Change in inventory | 115.49%922K | 225.57%3.65M | 39.72%-8.34M | 152.94%6.67M | -501.76%-6.14M | -315.64%-5.95M | -339.90%-2.91M | -816.70%-13.83M | -745.74%-12.59M | -178.24%-1.02M |
| -Change in prepaid assets | -242.84%-2.77M | 187.27%1.7M | -86.10%-5.16M | -171.46%-4.32M | 88.25%-825K | 81.84%1.94M | 32.13%-1.95M | -124.33%-2.77M | -57.27%6.05M | 43.06%-7.02M |
| -Change in payables and accrued expense | -523.64%-11.81M | -136.08%-10.52M | 159.57%46.55M | 117.27%16.48M | -149.71%-1.87M | 3.64%2.79M | 649.72%29.15M | 594.95%17.93M | 203.73%7.59M | -6.43%3.77M |
| -Change in other working capital | -171.59%-383K | -8.77%-372K | -1,309.84%-18.62M | -3,341.16%-14.21M | -1,366.56%-4.61M | 293.84%535K | -7.55%-342K | 43.18%-1.32M | 13.96%-413K | 40.08%-314K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -100.29%-126K | -101.75%-33.51M | 79.67%50.7M | 364.76%37.56M | -1,340.58%-13.24M | 400.31%42.99M | -258.53%-16.61M | -42.99%28.22M | -59.10%8.08M | -81.04%1.07M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 99.99%-6K | -7,375.00%-12.56M | -1,531.22%-86.83M | 81.63%-9K | -224,640.00%-11.24M | -65,679.13%-75.42M | 96.88%-168K | 70.83%-5.32M | 71.18%-49K | 97.51%-5K |
| Net PPE purchase and sale | ---6K | 65.48%-58K | 44.89%-178K | 79.59%-10K | --0 | --0 | 56.25%-168K | 56.76%-323K | 71.18%-49K | 97.51%-5K |
| Net business purchase and sale | ---- | ---- | ---74.15M | --1K | --1.26M | ---- | ---- | --0 | --0 | --0 |
| Net investment purchase and sale | --0 | ---12.5M | ---12.5M | --0 | ---12.5M | --0 | --0 | --0 | --0 | ---- |
| Net other investing changes | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---5M | --0 | --0 |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 99.99%-6K | -7,375.00%-12.56M | -1,531.22%-86.83M | 81.63%-9K | -224,640.00%-11.24M | -65,679.13%-75.42M | 96.88%-168K | 70.83%-5.32M | 71.18%-49K | 97.51%-5K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -1,096.08%-6.41M | 211.34%12.65M | 78.13%-6.21M | 123.62%2.39M | 132.84%3.3M | 89.73%-536K | -276.09%-11.36M | 25.03%-28.39M | -65.37%-10.11M | 58.10%-10.04M |
| Net issuance payments of debt | -212.50%-6.25M | 787.50%13.75M | 259.55%12.76M | 288.20%3.76M | 750.00%13M | 0.00%-2M | 0.00%-2M | -60.00%-8M | 0.00%-2M | -100.00%-2M |
| Net common stock issuance | --0 | --0 | 15.13%-18M | --0 | -20.31%-9.95M | --0 | -462.36%-8.05M | 39.39%-21.21M | -23.50%-8.65M | 64.04%-8.27M |
| Proceeds from stock option exercised by employees | ---- | ---- | -27.15%1.75M | --0 | 6.01%247K | ---- | ---- | -34.37%2.4M | -82.03%557K | 454.76%233K |
| Net other financing activities | -347.22%-161K | 15.40%-1.1M | -72.23%-2.72M | -5,188.46%-1.38M | --0 | ---36K | 15.86%-1.31M | -3.41%-1.58M | 87.91%-26K | --0 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -1,096.08%-6.41M | 211.34%12.65M | 78.13%-6.21M | 123.62%2.39M | 132.84%3.3M | 89.73%-536K | -276.09%-11.36M | 25.03%-28.39M | -65.37%-10.11M | 58.10%-10.04M |
| Net cash flow | ||||||||||
| Beginning cash position | -68.50%21.9M | -43.35%55.32M | -5.33%97.66M | -84.58%15.38M | -66.37%36.56M | -33.93%69.52M | -5.33%97.66M | -6.03%103.16M | 11.22%99.74M | 0.47%108.72M |
| Current changes in cash | 80.15%-6.54M | -18.79%-33.42M | -670.34%-42.34M | 2,018.20%39.94M | -135.94%-21.18M | -1,044.95%-32.96M | -1,456.65%-28.14M | 16.98%-5.5M | -115.45%-2.08M | 51.56%-8.98M |
| End cash Position | -58.01%15.35M | -68.50%21.9M | -43.35%55.32M | -43.35%55.32M | -84.58%15.38M | -66.37%36.56M | -33.93%69.52M | -5.33%97.66M | -5.33%97.66M | 11.22%99.74M |
| Free cash flow | -100.31%-132K | -100.07%-33.57M | 81.11%50.52M | 367.47%37.55M | -1,346.42%-13.24M | 393.71%42.99M | -266.23%-16.78M | -42.78%27.9M | -59.00%8.03M | -80.43%1.06M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion | -- | -- |
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.